To Combine CRISPR/Cas9 Genome Editing, Nanotech and Chemical Genetics toward in vivo Protein Kinase Analysis

Project Details

StatusActive
Effective start/end date04/1/19 → …

Funding

  • NIH - National Institute of General Medical Sciences-Federal: $84,146.00